Editorial commentary on the special issue of glia and neurological diseases

Fengfei Ding

doi:10.7555/JBR.36.20220800

Volume 36 Issue 5

Sep. 2022

Turn off MathJax

Article Contents

Article Navigation > The Journal of Biomedical Research > 2022 > 36(5): 297-298

Fengfei Ding. Editorial commentary on the special issue of glia and neurological diseases[J]. The Journal of Biomedical Research, 2022, 36(5): 297-298. doi: 10.7555/JBR.36.20220800

Citation:

Fengfei Ding. Editorial commentary on the special issue of glia and neurological diseases[J]. The Journal of Biomedical Research, 2022, 36(5): 297-298. doi: 10.7555/JBR.36.20220800

Fengfei Ding. Editorial commentary on the special issue of glia and neurological diseases[J]. The Journal of Biomedical Research, 2022, 36(5): 297-298. doi: 10.7555/JBR.36.20220800

Citation:

Fengfei Ding. Editorial commentary on the special issue of glia and neurological diseases[J]. The Journal of Biomedical Research, 2022, 36(5): 297-298. doi: 10.7555/JBR.36.20220800

PDF( 1589 KB)

Editorial commentary on the special issue of glia and neurological diseases

doi: 10.7555/JBR.36.20220800

Fengfei Ding^,

Department of Pharmacology, School of Basic Medical Sciences, State Key Laboratory of Medical Neurobiology and Ministry of Education Frontiers Center for Brain Science, Institutes of Brain Science, Shanghai Medical College, Fudan University, Shanghai 200032, China

More Information

Corresponding author: Fengfei Ding, Department of Pharmacology, School of Basic Medical Sciences, State Key Laboratory of Medical Neurobiology and Ministry of Education Frontiers Center for Brain Science, Institutes of Brain Science, Shanghai Medical College, Fudan University, No. 130 Dong An Road, Xuhui District, Shanghai 200032, China. Tel: +86-21-54237228, E-mail: fengfei_ding@fudan.edu.cn
Received: 2022-09-06
Accepted: 2022-09-07

Published: 2022-09-28

Issue Date: 2022-09-28

Abstract

CLC number: R741, Document code: B
The authors reported no conflict of interests.

FullText(HTML)

References(8)

References

[1]	Obara-Michlewska M. The contribution of astrocytes to obesity-associated metabolic disturbances[J]. J Biomed Res, 2022, 36(5): 299–311. doi: 10.7555/JBR.36.20200020
[2]	Zheng X, Wang W. Astrocyte transplantation for repairing the injured spinal cord[J]. J Biomed Res, 2022, 36(5): 312–320. doi: 10.7555/JBR.36.20220012
[3]	Jia H, Xie T. Tracers progress for positron emission tomography imaging of glial-related disease[J]. J Biomed Res, 2022, 36(5): 321–335. doi: 10.7555/JBR.36.20220017
[4]	Gong Z, Ba L, Zhang M. Dysfunction of the oligodendrocytes in amyotrophic lateral sclerosis[J]. J Biomed Res, 2022, 36(5): 336–342. doi: 10.7555/JBR.36.20220009
[5]	Li H, Chen Y, Niu J, et al. New insights into the immunologic role of oligodendrocyte lineage cells in demyelination diseases[J]. J Biomed Res, 2022, 36(5): 343–352. doi: 10.7555/JBR.36.20220016
[6]	Xi Yan, Junkui Shang, Runrun Wang, et al. Mechanisms regulating cerebral hypoperfusion in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy[J]. J Biomed Res, 2022, 36(5): 353–357. doi: 10.7555/JBR.36.20220208
[7]	Sun Q, Hu Y, Deng S, et al. A visualization pipeline for in vivo two-photon volumetric astrocytic calcium imaging[J]. J Biomed Res, 2022, 36(5): 358–367. doi: 10.7555/JBR.36.20220099
[8]	Wang R, Zhang J, Shang J, et al. Effects of different regional cerebral blood flow on white matter hyperintensity in CADASIL patients[J]. J Biomed Res, 2022, 36(5): 368–374. doi: 10.7555/JBR.36.20220006